Q Therapeutics, Inc. Issues Formal Update on Key Corporate and Operational Developments

Deborah Eppstein, PhD, President and CEO of Q Therapeutics , Inc. , an emerging biotechnology company utilizing its proprietary innovative technology to develop breakthrough cell therapy products for the treatment of debilitating diseases of the central nervous system, today issued a formal update in the form of a CEO letter posted to the Company's ... (more)

http://www.biospace.com/news_story.aspx?StoryID=282915&full=1